Immunoassay Market [Technology (Enzyme, Fluorescent, Chemiluminescence, Radioimmunoassay), Analyzers & Reagents, Applications (Infectious Diseases, Cancer, Endocrinology, Cardiology), End Users (Hospitals, Laboratory, Academics)]-Global Forecast to 2018

世界のイムノアッセイ(免疫測定)市場:酵素、蛍光、化学発光、放射免疫測定

◆タイトル:Immunoassay Market [Technology (Enzyme, Fluorescent, Chemiluminescence, Radioimmunoassay), Analyzers & Reagents, Applications (Infectious Diseases, Cancer, Endocrinology, Cardiology), End Users (Hospitals, Laboratory, Academics)]-Global Forecast to 2018
◆商品コード:MAM40116016
◆調査・発行会社:MarketsandMarkets
◆発行日:2013年11月
◆ページ数:315
◆レポート形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:世界
◆販売価格オプション(消費税別)
Single userUSD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"世界のイムノアッセイ(免疫測定)市場:酵素、蛍光、化学発光、放射免疫測定"について調査・分析し、イントロダクション、エグゼクティブサマリー、プレミアムインサイト、市場概観、市場の機会と課題、バリューチェーン分析、市場の動態、技術別分析、製品別分析、用途別分析、地域別分析、市場規模及び予測、競争状況、市場シェア分析、新製品発売、主要企業(ベンダー)分析等の情報をお届けいたします。

Immunoassay have evolved as an integral part of the modern medical care practice owing to the continuous technological advancements in this field, the increase in healthcare awareness among people, and the increasing use of immunoassay tests in diagnosis and monitoring.

This research report categorizes the global on the basis of technology, application, product (analyzers and reagents), and end user. On the basis of technology, the enzyme immunoassay segment accounted for the largest share of the global market in 2012. Long-term presence in the market, high sensitivity for infectious/viral disease testing, and the huge demand from developing countries due to the lower costs of enzyme immunoassay in comparison to chemiluminescence immunoassay (CLIA) are all factors that are responsible for its growing share in the market. On the basis of product, the reagents market accounted for the largest share of this market in 2012. The accessibility of a wide range of reagents and the need for reliable, specific, and faster detection of chronic diseases at early stages are factors that are expected to drive the immunoassay reagents market.

The infectious diseases segment in the market is a high-volume, high-growth rate market. Major players such as Roche Diagnostics, Ortho Clinical Diagnostics (J&J), and bioMérieux are continuously launching new product models in order to gain a competitive edge in the infectious diseases segment, primarily because of the high immunoassay penetration rate in this segment.

Geographically, the Americas commanded the largest market share of the global market, followed by Europe. The factors driving the growth of the market in these geographies are the well-established diagnostic infrastructure, aging population, and rising acceptance of personalized medicine. However, on the other hand, the economic downturn and cuts in healthcare budgets are hampering the growth of the market. Countries like China, India, Australia, and Brazil will be major contributors of the growth of the market in the future. This market in China is poised to grow at a CAGR of 15.6% from 2013 to 2018. Increasing investments by leading companies in these immature markets, rising public awareness about personal health, and improving healthcare infrastructure in these regions are driving the growth of the market.

The deviations and the overlap of revenues between the various segments, especially in applications quoted in a number of sources was the major challenge faced while estimating the market size. This challenge was overcome by validating the data through a large number of industry experts and key opinion leaders.

From an insight perspective, this research report focuses on the qualitative data, market size, share, and growth of various segments and sub-segments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis, such as market dynamics (drivers, restraints, opportunities, and threats), value chain, PESTEL analysis, porters five forces analysis, regulations, and reimbursement challenges. The report also offers market shares, sizes, and related growth of various segments of the industry. It also focuses on the emerging and high-growth segments of immunoassay (enzyme and chemiluminescence immunoassay), emerging technologies, high-growth regions, countries, and the initiatives of their respective governments.

The competitive landscape covers the growth strategies adapted by the industry players in the last three years. The company profiles comprise of the basic views on the key players in the market and the product portfolios, developments, and strategies adopted to maintain and grow their market shares in the near future. The above mentioned market research data, current market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovation in the products and technologies, and levels of output in order to remain successful.

Scope of the Report

This research report categorizes the global market on the basis of technology, application, product (analyzers and reagents), and end user. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2011, 2012, and 2013 as well as forecasts up to 2018. Each segment of the market is comprehensively analyzed at a granular level, by geography (Americas, Europe, APAC, and the Rest of the World), to provide in-depth information on the global scenario.

The global immunoassay market is segmented as follows:

By Technology:

Enzyme Immunoassay (EIA)
Fluorescent Immunoassay
Chemiluminescence Immunoassay (CLIA)
Radioimmunoassays (RIA)
Others (Nephelometric Immunoassay, Turbidimetric Immunoassay, and Counting Immunoassay (CIA))

By Application:

Oncology
Infectious Diseases
Cardiology
Bone and Mineral
Endocrinology
Autoimmunity
Toxicology
Hematology (Anemia)
Neonatal Screening
Others

By Product:

Analyzers
High-throughput
Medium-throughput
Low-throughput
Reagents

By End User:

Hospitals (Private and Public)
Laboratories (Private and Public)
Academics
Pharmaceutical Industry, CROs, and Biotechs
Others

By Geography:

Americas
U.S.
Canada
Brazil
Mexico
RoA (Rest of Americas)
Europe
Germany
France
U.K.
Spain
Italy
RoE (Rest of Europe)
Asia-Pacific
Japan
China
India
South Korea
RoAP (Rest of Asia-Pacific)
RoW (Rest of World) (Middle East and Africa)

【レポートの目次】

1 Introduction (Page No. – 30)
1.1 Key Take-Aways
1.2 Report Description
1.3 Research Methodology
1.3.1 Secondary Sources
1.3.2 Primary Sources
1.3.3 Market Size Estimation
1.3.4 Market Share
1.3.5 Key Data Points From Secondary Sources
1.3.6 Key Data Points From Primary Sources
1.3.7 Assumptions
1.4 Markets Covered
1.5 Stakeholders
1.6 Market Scope

2 Executive Summary (Page No. – 45)

3 Premium Insights (Page No. – 48)
3.1 Immunoassay Market Vs Other IVD Market Segments
3.2 Geographic Analysis, By Country
3.3 Applications Market
3.4 End-User Analysis
3.5 Competitive Analysis

4 Industry Analysis & Market Overview (Page No. – 54)
4.1 Introduction
4.2 Evolution
4.3 Market Segmentation
4.4 Market Dynamics
4.4.1 Drivers
4.4.1.1 Rising Incidence Of Chronic And Infectious Diseases In Emerging Economies To Drive The Immunoassay Market
4.4.1.2 Rapidly Aging Population Will Result In Increasing Chronic Diseases
4.4.1.3 Growing Popularity Of Portable Immunoassay To Stimulate Growth
4.4.1.4 Novel Biomarkers And Innovative Technologies To Give An Edge To Immunoassay Companies
4.4.1.5 Sensitive, Cost-Effective, & Rapidness Of Immunoassay Increases Adoption Rates
4.4.1.6 Increasing Health Awareness Responsible For The Growth Of The Immunoassay Market
4.4.2 Restraints
4.4.2.1 Low Detection Limits Restrict Adoption Of Immunoassay Tests
4.4.2.2 Lack Of Budget To Restrict Growth
4.4.3 Opportunities
4.4.3.1 New Range Of Condition-Specific Markers And Tests With Advances In Genomics And Proteomics
4.4.3.2 Increasing Adoption In Emerging Markets Such As China And India Are Creating Growth Opportunities For The Immunoassay Market
4.4.4 Threats
4.4.4.1 Pricing Pressure For Some Tests Due To Competition From Lower Cost-Per-Test Technologies
4.4.4.2 Stringent Regulatory Framework Acts As A Major Challenge
4.5 Burning Issues
4.5.1 Lateral Flow Immunoassay
4.5.1.1 Demand For LF Tests On The Rise
4.5.2 Laboratory Automation For Increased Efficiency And Accurate Diagnosis
4.6 Techniques To Validate New Biomarkers Using Immunoassay
4.7 Regulations
4.7.1 U.S.
4.7.2 Europe
4.7.3 Japan
4.7.4 China
4.7.5 India
4.8 Reimbursement Scenario & Challenges
4.9 Value Chain Analysis
4.10 Porter’s Analysis
4.10.1 Threat From New Entrants
4.10.2 Threat From Substitutes
4.10.3 Bargaining Power Of Buyers
4.10.4 Bargaining Power Of Suppliers
4.10.5 Competitive Rivalry Among Existing Players
4.11 Pestel Analysis
4.11.1 Political
4.11.2 Economic
4.11.3 Socio-Cultural
4.11.4 Technological
4.11.5 Environmental
4.11.6 Legal
4.12 Market Share Analysis
4.12.1 Global
4.12.2 Americas
4.12.3 Europe
4.12.4 Asia-Pacific

5 Immunoassay Market, By Technology (Page No. – 86)
5.1 Introduction
5.2 Enzyme Immunoassay (EIA)
5.2.1 EIA Is The Most Preferred Technique In The Immunoassay Market
5.3 Fluorescence Immunoassay (FIA)
5.3.1 Sensitivity Along With Low Cost Of FIA Drives The Market
5.4 Chemiluminescence Immunoassay (CLIA)
5.4.1 High Sensitivity, Automation & Wide Applications Of CLIA Responsible For The Highest Growth
5.5 Radioimmunoassays (RIA)
5.5.1 Despite Wide Applications & High Sensitivity, RIA To Lose Share To Safer Technologies Like EIA & CLIA
5.6 Others [Nephelometry, Turbidimetry, & Counting Immunoassay (CIA)]
5.6.1 Nephelometry Will Grow At A Meager Pace Due To Lack Of Major Advancements
5.6.2 Turbidometry & CIA To Grow At A Decent Rate
5.7 The Immunoassay Market Vs. Other IVD Segments
5.7.1 Immunoassay Contribute The Highest To IVD Market; Molecular Diagnostics Segment Will Grow The Fastest

6 Immunoassay Market, By Products (Analyzers & Reagents) (Page No. – 118)
6.1 Introduction
6.1.1 Reagents Market To Grow With Increase In Test Volumes
6.2 Analyzers
6.2.1 Medium-Throughput Analyzers Contribute The Highest To The Analyzers Revenue
6.2.2 High-Throughput Analyzers
6.2.2.1 High Throughput Analyzers Will Witness The Fastest Growth
6.2.3 Medium-Throughput Analyzers
6.2.4 Low-Throughput Analyzers
6.3 Reagents
6.3.1 Home Brew Assays Are Subject To Lenient Regulations

7 Immunoassay Market, By Application (Page No. – 132)
7.1 Introduction
7.2 Oncology
7.2.1 Oncology Biomarkers Can Help Early Detection Of Cancers
7.3 Endocrinology
7.3.1 Endocrinology Segment Will Be Driven By Increasing Incidences Of Diabetes & Thyroid Disorders
7.4 Bone & Mineral
7.4.1 Increasing Prevalence Of Bone & Mineral Disorders To Propel The Immunoassay Market
7.5 Cardiology
7.5.1 Immunoassay Techniques Are Frequently Used For Diagnosis Of Cardiac Ailments
7.5.2 Troponin Is The Most Preferred Biomarker In Cardiology
7.6 Infectious Diseases
7.6.1 Increasing Investments In The Infectious Diseases Due To High-Share, High-Growth Rate Nature Of The Segment
7.7 Hematology
7.8 Autoimmunity
7.8.1 Autoimmunity Segment Provides Significant Growth Opportunities To Immunoassay Players
7.9 Toxicology
7.9.1 Increasing Drug-Abuse Cases To Boost Immunoassay Toxicology Market
7.10 Neonatal Screening
7.10.1 Novel Biomarkers Identified For Newborn Screening In Public Health Practices
7.11 Others (Allergy, Stool Testing, & Serology)

8 Global Immunoassay Market, By End-Users (Page No. – 161)
8.1 Introduction
8.2 Hospitals (Private/Public)
8.2.1 Hospitals As End-Users Is A High Growth Rate, High Market Size Segment
8.3 Laboratories (Private/Public)
8.3.1 Laboratories Offer Various Advantages Over Hospitals Yet Will Grow At Lower Rate Due To Smaller Volumes
8.4 Academics
8.5 Pharmaceutical Industry, Cros, & Biotechs
8.5.1 Increasing Research Activities To Drive The Industrial Segment
8.6 Others (Physicians’ Offices, Blood Banks, Patient Self-Testing, & Ambulatory Centers)
8.6.1 The Demand For PST Is On A Rise

9 Geographic Analysis (Page No. – 169)
9.1 Introduction
9.1.1 U.S. The Major Contributor To Immunoassay Owing To Technological Advancements & Government Support
9.1.2 Asian And Latam Countries Offer Huge Opportunities To Investors
9.2 The Americas
9.2.1 U.S.
9.2.1.1 PPACA Has A Positive Impact On Immunoassay Business
9.2.1.2 Despite Unfavorable Conditions Key Players Look To Consolidate Their Business In U.S.
9.2.2 Canada
9.2.3 Mexico
9.2.3.1 Government Regulations & Reforms Support The Growth Of Immunoassay In Mexico
9.2.4 Brazil
9.2.4.1 Healthcare Reforms, Government Initiatives & Rise Of Infectious Diseases To Drive The Brazilian Immunoassay Market
9.2.5 Rest Of Americas (ROA)
9.3 Europe
9.3.1 Europe Immunoassay Market Will Grow At A Slow Pace Due To Decreased Funding & Strict Regulatory Guidelines
9.3.2 Germany
9.3.2.1 Germany To Grow At A High Pace Due To Presence Of Defined Outsourcing Chain Of Laboratory Services & Government Support
9.3.3 France
9.3.3.1 France Is The Second Biggest Immunoassay Market In Europe
9.3.4 Italy
9.3.4.1 Italy Will Grow At A Decent Pace Despite Various Challenges
9.3.5 Spain
9.3.5.1 Spain To Grow At A Meager Pace Due To Budget Cuts And Late Payments
9.3.6 U.K.
9.3.6.1 U.K.To Grow At The Fastest Rate In Europe Despite Roadblocks
9.3.7 Rest Of Europe (ROE)
9.4 Asia-Pacific
9.4.1 Japan
9.4.1.1 Japanese Immunoassay Market To Grow The Slowest In Asia Due To Regulatory Issues & Diagnostic Lag
9.4.2 India
9.4.2.1 Large Population Base, Increased Affordability & Government Initiatives Drive The Indian Immunoassay Market
9.4.3 China
9.4.3.1 China Will Be The Fastest Growing Immunoassay Market, Globally
9.4.4 South Korea
9.4.4.1 South Korea To Witness Double-Digit Growth In The Immunoassay Arena
9.4.5 Taiwan
9.4.5.1 Taiwan To Grow At Brisk Pace In The Immunoassay Business
9.4.6 ROAP
9.5 Rest Of The World (ROW)

10 Competitive Landscape (Page No. – 262)
10.1 Introduction
10.1.1 Agreements, Partnerships & JVS Is The Key Growth Strategy Adopted By Players
10.2 Agreements, Partnerships, Collaborations, & Joint Ventures
10.3 New Product Launches
10.4 Mergers & Acquisitions
10.5 Other Developments

11 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments) * (Page No. – 270)
11.1 Abbott Laboratories, Inc.
11.2 Alere, Inc.
11.3 Becton, Dickinson And Company
11.4 Biomérieux
11.5 Danaher Corporation (Beckman Coulter)
11.6 Diasorin S.P.A
11.7 Diasource Immunoassays S.A.
11.8 DRG International, Inc.
11.9 Hologic (Gen-Probe )
11.10 IBL International GMBH
11.11 IDS Plc
11.12 Meridian Life Science, Inc.
11.13 Ortho Clinical Diagnostics (A J&J Company)
11.14 Qiagen N.V.
11.15 Roche Diagnostics Limited
11.16 Siemens Healthcare
11.17 Sysmex Corporation
11.18 Thermo Fisher Scientific, Inc. (Brahms)

List Of Tables (118 Tables)

Table 1 Global Market, By Technology, 2011-2018 ($Million)
Table 2 Enzyme Immunoassays Market, By Geography, 2011-2018 ($Million)
Table 3 Americas: Market, By Country, 2011-2018 ($Million)
Table 4 Europe: Market, By Country, 2011-2018 ($Million)
Table 5 Asia-Pacific: Market, By Country, 2011-2018 ($Million)
Table 6 Fluorescent Immunoassays Market, By Geography, 2011-2018 ($Million)
Table 7 Americas: Market, By Country, 2011-2018 ($Million)
Table 8 Europe: Market, By Country, 2011-2018 ($Million)
Table 9 Asia-Pacific: Market, By Country, 2011-2018 ($Million)
Table 10 Chemiluminescence Immunoassays Market, By Geography, 2011-2018 ($Million)
Table 11 Americas: Market, By Country, 2011-2018 ($Million)
Table 12 Europe: Market, By Country, 2011-2018 ($Million)
Table 13 Asia-Pacific: Market, By Country, 2011-2018 ($Million)
Table 14 Radioimmunoassays Market, By Geography, 2011-2018 ($Million)
Table 15 Americas: Market, By Country, 2011-2018 ($Million)
Table 16 Europe: Market, By Country, 2011-2018 ($Million)
Table 17 Asia-Pacific: Market, By Country, 2011-2018 ($Million)
Table 18 Other Immunoassays Market, By Geography, 2011-2018 ($Million)
Table 19 Americas: Market, By Country, 2011-2018 ($Million)
Table 20 Europe: Market, By Country, 2011-2018 ($Million)
Table 21 Asia-Pacific: Market, By Country, 2011-2018 ($Million)
Table 22 Global In Vitro Diagnostics Market, By Technique, 2011-2018 ($Million)
Table 23 Global Market, By Product, 2011-2018 ($Million)
Table 24 Global Market, By Throughput, 2011-2018 ($Million)
Table 25 Immunoassay Analyzers Market, By Geography, 2011-2018 ($Million)
Table 26 Americas: Market, By Country, 2011-2018 ($Million)
Table 27 Europe: Market, By Country, 2011-2018 ($Million)
Table 28 Asia-Pacific: Market, By Country, 2011-2018 ($Million)
Table 29 Immunoassay Reagents Market, By Geography, 2011-2018 ($Million)
Table 30 Americas: Market, By Country, 2011-2018 ($Million)
Table 31 Europe: Market, By Country, 2011-2018 ($Million)
Table 32 Asia-Pacific: Market, By Country, 2011-2018 ($Million)
Table 33 Global Immunoassay Market, By Application, 2011-2018 ($Million)
Table 34 Oncology Immunoassay Market, By Geography, 2011-2018 ($Million)
Table 35 Endocrinology Immunoassay Market, By Geography, 2011-2018 ($Million)
Table 36 Bone & Mineral Immunoassay Market, By Geography, 2011-2018 ($Million)
Table 37 Commonly Used Cardiac Biomarker Tests
Table 38 Cardiac Biomarker Tests Used For Prognosis
Table 39 Cardiology Immunoassay Market, By Geography, 2011-2018 ($Million)
Table 40 Infectious Diseases Immunoassay Market, By Geography, 2011-2018 ($Million)
Table 41 Hematology Immunoassay Market, By Geography, 2011-2018 ($Million)
Table 42 Autoimmunity Immunoassay Market, By Geography, 2011-2018 ($Million)
Table 43 Toxicology Immunoassay Market, By Geography, 2011-2018 ($Million)
Table 44 Neonatal Screening Immunoassays Market, By Geography, 2011-2018 ($Million)
Table 45 Other Immunoassay Applications Market, By Geography, 2011-2018 ($Million)
Table 46 Global Immunoassay Market, By End-Users, 2011-2018 ($Million)
Table 47 Immunoassay Market, By Geography, 2011-2018 ($Million)
Table 48 The Americas: Immunoassay Market, By Country, 2011-2018 ($Million)
Table 49 The Americas: Market, By Technology, 2011-2018 ($Million)
Table 50 Americas: Market, By Product, 2011-2018 ($Million)
Table 51 Americas: Market, By Application, 2011-2018 ($Million)
Table 52 U.S.: Immunoassay Market, By Technology, 2011-2018 ($Million)
Table 53 U.S.: Immunoassay Market, By Product, 2011-2018 ($Million)
Table 54 U.S.: Market, By Application, 2011-2018 ($Million)
Table 55 Canada: Immunoassay Market, By Technology, 2011-2018 ($Million)
Table 56 Canada: Market, By Product, 2011-2018 ($Million)
Table 57 Canada: Market, By Application, 2011-2018 ($Million)
Table 58 Mexico: Immunoassay Market, By Technology, 2011-2018 ($Million)
Table 59 Mexico: Market, By Product, 2011-2018 ($Million)
Table 60 Mexico: Market, By Application, 2011-2018 ($Million)
Table 61 Brazil: Immunoassay Market, By Technology, 2011-2018 ($Million)
Table 62 Brazil: Market, By Product, 2011-2018 ($Million)
Table 63 Brazil: Market, By Application, 2011-2018 ($Million)
Table 64 ROA: Immunoassay Market, By Technology, 2011-2018 ($Million)
Table 65 ROA: Market, By Product, 2011-2018 ($Million)
Table 66 ROA: Market, By Application, 2011-2018 ($Million)
Table 67 Europe: Market, By Country, 2011-2018 ($Million)
Table 68 Europe: Market, By Technology, 2011-2018 ($Million)
Table 69 Europe: Immunoassay Market, By Product, 2011-2018 ($Million)
Table 70 Europe: Immunoassay Market, By Application, 2011-2018 ($Million)
Table 71 Germany:Market, By Technology, 2011-2018 ($Million)
Table 72 Germany: Immunoassay Market, By Product, 2011-2018 ($Million)
Table 73 Germany: Market, By Application, 2011-2018 ($Million)
Table 74 France: Immunoassay Market, By Technology, 2011-2018 ($Million)
Table 75 France: Market, By Product, 2011-2018 ($Million)
Table 76 France: Market, By Application, 2011-2018 ($Million)
Table 77 Italy: Immunoassay Market, By Technology, 2011-2018 ($Million)
Table 78 Italy: Market, By Product, 2011-2018 ($Million)
Table 79 Italy: Market, By Application, 2011-2018 ($Million)
Table 80 Spain: Immunoassay Market, By Technology, 2011-2018 ($Million)
Table 81 Spain: Market, By Product, 2011-2018 ($Million)
Table 82 Spain: Market, By Application, 2011-2018 ($Million)
Table 83 U.K.: Immunoassay Market, By Technology, 2011-2018 ($Million)
Table 84 U.K.: Market, By Product, 2011-2018 ($Million)
Table 85 U.K.: Market, By Application, 2011-2018 ($Million)
Table 86 ROE: Immunoassay Market, By Technology, 2011-2018 ($Million)
Table 87 ROE: Market, By Product, 2011-2018 ($Million)
Table 88 ROE: Market, By Application, 2011-2018 ($Million)
Table 89 Asia-Pacific: Immunoassay Market, By Country, 2011-2018 ($Million)
Table 90 Asia-Pacific: Immunoassay Market, By Technology, 2011-2018 ($Million)
Table 91 Asia-Pacific: Market, By Product, 2011-2018 ($Million)
Table 92 Asia-Pacific: Market, By Application, 2011-2018 ($Million)
Table 93 Japan: Immunoassay Market, By Technology, 2011-2018 ($Million)
Table 94 Japan: Immunoassay Market, By Product, 2011-2018 ($Million)
Table 95 Japan: Market, By Application, 2011-2018 ($Million)
Table 96 India: Immunoassay Market, By Technology, 2011-2018 ($Million)
Table 97 India: Immunoassay Market, By Product, 2011-2018 ($Million)
Table 98 India: Market, By Application, 2011-2018 ($Million)
Table 99 China: Immunoassay Market, By Technology, 2011-2018 ($Million)
Table 100 China: Market, By Product, 2011-2018 ($Million)
Table 101 China: Immunoassays Market, By Application, 2011-2018 ($Million)
Table 102 South Korea: Immunoassay Market, By Technology, 2011-2018 ($Million)
Table 103 South Korea: Immunoassay Market, By Product, 2011-2018 ($Million)
Table 104 South Korea: Market, By Application, 2011-2018 ($Million)
Table 105 Taiwan: Immunoassay Market, By Technology, 2011-2018 ($Million)
Table 106 Taiwan: Market, By Product, 2011-2018 ($Million)
Table 107 Taiwan: Market, By Application, 2011-2018 ($Million)
Table 108 ROAP: Immunoassay arket, By Technology, 2011-2018 ($Million)
Table 109 ROAP: Market, By Product, 2011-2018 ($Million)
Table 110 ROAP: Market, By Application, 2011-2018 ($Million)
Table 111 ROW: Immunoassay Market, By Technology, 2011-2018 ($Million)
Table 112 ROW: Immunoassay Market, By Product, 2011-2018 ($Million)
Table 113 ROW: Market, By Application, 2011-2018 ($Million)
Table 114 Agreements, Partnerships, Collaborations, & Joint Ventures (2010-2013)
Table 115 New Product Launches (2010-2013)
Table 116 Mergers & Acquisitions (2010-2013)
Table 117 Other Developments (2011-2013)
Table 118 Appendix: Other Developments (2010-2013)


List Of Figures (86 Figures)

Figure 1 Research Methodology For The Immunoassays Market
Figure 2 Market Size Estimation Methodology For The Immunoassays Market
Figure 3 Forecast Model
Figure 4 Data Triangulation Methodology (360o Evaluation)
Figure 5 Global Immunoassays Market, By Technology, 2013-2018 ($Million)
Figure 6 Comparison Of Immunoassay & Other IVD Segments (2013)
Figure 7 Immunoassay Market: Geographic Analysis, 2013 ($Million)
Figure 8 Immunoassay Market: By Applications, 2011-2018 (Market Size & Growth Rates)
Figure 9 Immunoassay Market: By Applications, 2013
Figure 10 Immunoassay Market: End-User Analysis, 2013 Vs 2018
Figure 11 Immunoassay Market Key Players: Geographic Reach Vs Product Portfolio (2013)
Figure 12 Immunoassay Market Evolution
Figure 13 Immunoassay Market Segmentation
Figure 14 Immunoassay Market Dynamics
Figure 15 Approval Process Flowchart
Figure 16 Immunoassay Market: Value Chain Analysis For Instruments
Figure 17 Porter’s Five Forces Analysis: Immunoassay Market
Figure 18 Pestel Analysis: Immunoassay Market
Figure 19 Global Immunoassay Market Share Analysis, By Key Players, 2012
Figure 20 Americas: Immunoassay Market Share Analysis, By Key Players, 2012
Figure 21 Europe: Immunoassay Market Share Analysis, By Key Players, 2012
Figure 22 Asia-Pacific: Immunoassay Market Share Analysis, By Key Players, 2012
Figure 23 Global In Vitro Diagnostics Market, By Technique, 2013 ($Million)
Figure 24 Global Immunoassay Market, By Application, 2013-2018
Figure 25 Global Immunoassay Market, End-User Positioning
Figure 26 Global Immunoassay Market, By End-Users, 2013-2018
Figure 27 Immunoassay Market: Geographic Phases, 2013
Figure 28 Opportunity Matrix: Immunoassay Market, By Country, 2013-2018 ($Million)
Figure 29 Key Growth Strategy, 2010-2013
Figure 30 Abbott Laboratories, Inc.: Total Revenue ($Million) & Operating Margin (%), 2010-2012
Figure 31 Abbott Laboratories, Inc.: Business Revenue Mix, 2012
Figure 32 Abbott Laboratories, Inc.: Geographic Revenue Mix, 2012
Figure 33 Abbott Laboratories, Inc.: Market Strategy, 2011-2013
Figure 34 Alere, Inc.: Total Revenue ($Million) & Operating Margin (%), 2010-2012
Figure 35 Alere, Inc.: Business Revenue Mix, 2012
Figure 36 Alere, Inc.: Geographic Revenue Mix, 2012
Figure 37 Alere, Inc. Market Strategy, 2011-2013
Figure 38 Becton, Dickinson And Company: Total Revenue ($Million) & Operating Margin (%), 2010-2012
Figure 39 Becton, Dickinson And Company: Business Revenue Mix, 2012
Figure 40 Becton, Dickinson And Company: Geographic Revenue Mix, 2012
Figure 41 Becton, Dickinson And Company: Market Strategy, 2011-2013
Figure 42 Biomérieux: Total Revenue ($Million) & Operating Margin (%), 2010-2012
Figure 43 Biomérieux: Business Revenue Mix, 2012
Figure 44 Biomérieux: Geographic Revenue Mix, 2012
Figure 45 Biomérieux: Market Strategy, 2011-2013
Figure 46 Danaher Corporation: Total Revenue ($Million) & Operating Margin (%), 2010-2012
Figure 47 Danaher Corporation: Business Revenue Mix, 2012
Figure 48 Danaher Corporation: Geographic Revenue Mix, 2012
Figure 49 Danaher Corporation: Market Strategy, 2011-2013
Figure 50 Diasorin S.P.A.: Total Revenue ($Million) & Operating Margin (%), 2010-2012
Figure 51 Diasorin S.P.A.: Business Revenue Mix, 2012
Figure 52 Diasorin S.P.A.: Geographic Revenue Mix, 2012
Figure 53 Diasorin S.P.A.: Market Strategy, 2011-2013
Figure 54 Hologic, Inc.: Total Revenue ($Million) & Operating Margin (%), 2010-2012
Figure 55 Hologic, Inc.: Business Revenue Mix, 2012
Figure 56 Hologic, Inc.: Geographic Revenue Mix, 2011
Figure 57 Hologic, Inc.: Market Strategy, 2011-2013
Figure 58 IDS PLC.: Total Revenue, 2011-2013
Figure 59 IDS PLC.: Business Revenue Mix, 2013
Figure 60 IDS PLC.: Geographic Revenue Mix, 2013
Figure 61 Meridian Bioscience, Inc.: Total Revenue ($Million) & Operating Margin (%), 2010-2012
Figure 62 Meridian Bioscience, Inc.: Business Revenue Mix, 2012
Figure 63 Johnson & Johnson: Total Revenue ($Million) & Operating Margin (%), 2010-2012
Figure 64 Johnson & Johnson: Business Revenue Mix, 2012
Figure 65 Johnson & Johnson: Geographic Revenue Mix, 2012
Figure 66 Johnson & Johnson: Market Strategy, 2011-2013
Figure 67 Qiagen N.V.: Total Revenue ($Million) & Operating Margin (%), 2010-2012
Figure 68 Qiagen N.V.: Business Revenue Mix, 2012
Figure 69 Qiagen N.V.: Geographic Revenue Mix, 2012
Figure 70 Qiagen N.V.: Market Strategy, 2011-2013
Figure 71 Roche Diagnostics: Total Diagnostics Revenue ($Million) & Operating Margin (%), 2010-2012
Figure 72 Roche Diagnostics: Business Revenue Mix (Diagnostics Division), 2012
Figure 73 Roche Diagnostics: Geographic Revenue Mix (Diagnostics Division), 2012
Figure 74 Roche Diagnostics: Market Strategy, 2011-2013
Figure 75 Siemens Healthcare: Total Revenue, 2010-2012
Figure 76 Siemens Healthcare: Business Revenue Mix, 2012
Figure 77 Siemens Healthcare: Geographic Revenue Mix, 2012
Figure 78 Siemens Healthcare: Market Strategy, 2011-2013
Figure 79 Sysmex Corporation: Total Revenue ($Million), 2011-2013
Figure 80 Sysmex Corporation: Business Revenue Mix, 2013
Figure 81 Sysmex Corporation: Geographic Revenue Mix, 2013
Figure 82 Sysmex Corporation: Market Strategy, 2011-2013
Figure 83 Thermo Fisher Scientific, Inc.: Total Revenue ($Million) & Operating Margin (%), 2010-2012
Figure 84 Thermo Fisher Scientific, Inc.: Business Revenue Mix, 2012
Figure 85 Thermo Fisher Scientific, Inc.: Geographic Revenue Mix, 2012
Figure 86 Thermo Fisher Scientific, Inc.: Market Strategy, 2011-2013

★調査レポート[世界のイムノアッセイ(免疫測定)市場:酵素、蛍光、化学発光、放射免疫測定] ( Immunoassay Market [Technology (Enzyme, Fluorescent, Chemiluminescence, Radioimmunoassay), Analyzers & Reagents, Applications (Infectious Diseases, Cancer, Endocrinology, Cardiology), End Users (Hospitals, Laboratory, Academics)]-Global Forecast to 2018 / MAM40116016) 販売に関する免責事項
[世界のイムノアッセイ(免疫測定)市場:酵素、蛍光、化学発光、放射免疫測定] ( Immunoassay Market [Technology (Enzyme, Fluorescent, Chemiluminescence, Radioimmunoassay), Analyzers & Reagents, Applications (Infectious Diseases, Cancer, Endocrinology, Cardiology), End Users (Hospitals, Laboratory, Academics)]-Global Forecast to 2018 / MAM40116016) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆